SINTX Technologies Announces Grant of New U.S Patent For Antibacterial Applications of Silicon Nitride
October 28 2020 - 9:00AM
SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT) (“SINTX” or
the “Company”), a manufacturer of silicon nitride ceramic for
medical and non-medical applications, today announced that the
United States Patent and Trademark Office has issued US Patent
10,806,831 covering antibacterial biomedical implants and
associated materials. This newly issued patent broadly covers a
variety of biomedical implants wherein the Company’s silicon
nitride is applied to improve the antibacterial characteristics of
the implant.
“The antibacterial characteristics of SINTX’s
silicon nitride were identified in 2012, and have been confirmed by
multiple independent studies. We have developed and tested powders,
coatings, and composites of silicon nitride that extend the
technology to other material platforms,” said Dr. Sonny Bal
President, and CEO of SINTX Technologies.
In the biomedical space, beyond monolithic
silicon nitride implants that are already FDA-approved, SINTX can
now add its material to widely-used biomaterials such as PEEK and
titanium. The Company has already developed a composite of silicon
nitride and PEEK and expects to launch the product in early
2021.
SINTX provides silicon nitride in other forms
such as sintered powders and soluble fractions, which expand its
technology portfolio yet further. The different forms of silicon
nitride allow SINTX to include it in a variety of applications such
as fabrics for catch-and-kill face masks that can neutralize
respiratory pathogens. The newly-issued patent is an important
milestone in SINTX’s strategy to leverage the antipathogenic
properties of silicon nitride, and it adds to a growing IP
portfolio in that space.
About SINTX Technologies, Inc.
SINTX Technologies is an OEM ceramics company
that develops and commercializes silicon nitride for medical and
non-medical applications. The core strength of SINTX Technologies
is the manufacturing, research, and development of silicon nitride
ceramics for external partners. The Company presently manufactures
silicon nitride powders and components in its FDA registered and
ISO 13485:2016 certified manufacturing facility.
For more information on SINTX Technologies
or its silicon nitride material platform, please
visit www.sintx.com.
Forward-Looking Statements
This press release contains forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995 (PSLRA) that are subject to a number of risks
and uncertainties. Risks and uncertainties that may cause such
differences include, among other things: incorporation of silicon
nitride into personal protective equipment and other products may
not be safe or effective; volatility in the price of SINTX’s common
stock; the uncertainties inherent in new product development,
including the cost and time required to commercialize such
product(s); market acceptance of our products once commercialized;
SINTX’s ability to raise additional funding and other competitive
developments. Readers are cautioned not to place undue reliance on
the forward-looking statements, which speak only as of the date on
which they are made and reflect management’s current estimates,
projections, expectations and beliefs. There can be no assurance
that any of the anticipated results will occur on a timely basis or
at all due to certain risks and uncertainties, a discussion of
which can be found in SINTX’s Risk Factors disclosure in its Annual
Report on Form 10-K, filed with the Securities and Exchange
Commission (SEC) on March 26, 2020, and in SINTX’s other filings
with the SEC. SINTX disclaims any obligation to update any
forward-looking statements. SINTX undertakes no obligation to
publicly revise or update the forward-looking statements to reflect
events or circumstances that arise after the date of this
report.
Business Inquiries for SINTX:SINTX
Technologies801.839.3502IR@sintx.com
Media Inquiries for SINTX: Amanda Barry
Associate Director, Content and PR The Summit Group
abarry@summitslc.com
SiNtx Technologies (NASDAQ:SINT)
Historical Stock Chart
From Mar 2024 to Apr 2024
SiNtx Technologies (NASDAQ:SINT)
Historical Stock Chart
From Apr 2023 to Apr 2024